These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 1951550)

  • 1. Glycogen phosphorylase isoenzyme BB plasma concentration is elevated in pregnancy and preterm preeclampsia.
    Lee J; Romero R; Dong Z; Lee DC; Dong Y; Mittal P; Chaiworapongsa T; Hassan SS; Kim CJ
    Hypertension; 2012 Feb; 59(2):274-82. PubMed ID: 22215716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Herpesviruses 6A and 6B in Reproductive Diseases.
    Komaroff AL; Rizzo R; Ecker JL
    Front Immunol; 2021; 12():648945. PubMed ID: 33841432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Giants in Obstetrics and Gynecology Series: A profile of James M. Roberts, MD.
    Romero R
    Am J Obstet Gynecol; 2019 Jun; 220(6):527-536.e1. PubMed ID: 31151587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 Long-Chain Polyunsaturated Fatty Acids and Preeclampsia: Trials Say "No," but Is It the Final Word?
    Burchakov DI; Kuznetsova IV; Uspenskaya YB
    Nutrients; 2017 Dec; 9(12):. PubMed ID: 29244779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of miR-203 expression induces endothelial inflammatory response: Potential role in preeclampsia.
    Wang Y; Dong Q; Gu Y; Groome LJ
    Am J Reprod Immunol; 2016 Dec; 76(6):482-490. PubMed ID: 27753461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress in preeclampsia and the role of free fetal hemoglobin.
    Hansson SR; Nääv Å; Erlandsson L
    Front Physiol; 2014; 5():516. PubMed ID: 25628568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Platelet-associated regulatory system (PARS)" with particular reference to female reproduction.
    Bódis J; Papp S; Vermes I; Sulyok E; Tamás P; Farkas B; Zámbó K; Hatzipetros I; Kovács GL
    J Ovarian Res; 2014; 7():55. PubMed ID: 24883111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease.
    Powe CE; Levine RJ; Karumanchi SA
    Circulation; 2011 Jun; 123(24):2856-69. PubMed ID: 21690502
    [No Abstract]   [Full Text] [Related]  

  • 9. Maternal levels of prostacyclin, thromboxane, ICAM, and VCAM in normal and preeclamptic pregnancies.
    Lewis DF; Canzoneri BJ; Gu Y; Zhao S; Wang Y
    Am J Reprod Immunol; 2010 Dec; 64(6):376-83. PubMed ID: 20482519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use.
    Wu FT; Stefanini MO; Mac Gabhann F; Kontos CD; Annex BH; Popel AS
    J Cell Mol Med; 2010 Mar; 14(3):528-52. PubMed ID: 19840194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chymotrypsin-like protease (chymase) mediates endothelial activation by factors derived from preeclamptic placentas.
    Yang Gu ; Chang Liu ; Alexander JS; Groome LJ; Yuping Wang
    Reprod Sci; 2009 Sep; 16(9):905-13. PubMed ID: 19494363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trap.
    Wu FT; Stefanini MO; Mac Gabhann F; Popel AS
    PLoS One; 2009; 4(4):e5108. PubMed ID: 19352513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2.
    Winn VD; Gormley M; Paquet AC; Kjaer-Sorensen K; Kramer A; Rumer KK; Haimov-Kochman R; Yeh RF; Overgaard MT; Varki A; Oxvig C; Fisher SJ
    Endocrinology; 2009 Jan; 150(1):452-62. PubMed ID: 18818296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of endothelial dysfunction in preeclampsia and risk of adverse pregnancy outcome.
    Powers RW; Catov JM; Bodnar LM; Gallaher MJ; Lain KY; Roberts JM
    Reprod Sci; 2008 Apr; 15(4):374-381. PubMed ID: 18187406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of preeclampsia.
    Mutter WP; Karumanchi SA
    Microvasc Res; 2008 Jan; 75(1):1-8. PubMed ID: 17553534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology and maternal biologic markers of preeclampsia.
    Massé J; Giguère Y; Kharfi A; Girouard J; Forest JC
    Endocrine; 2002 Oct; 19(1):113-25. PubMed ID: 12583608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone.
    Taylor RN; Crombleholme WR; Friedman SA; Jones LA; Casal DC; Roberts JM
    Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 1):895-901. PubMed ID: 1951550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Third trimester maternal plasma total fibronectin levels in pregnancy-induced hypertension: results of a tertiary center.
    Aydin T; Varol FG; Sayin NC
    Clin Appl Thromb Hemost; 2006 Jan; 12(1):33-9. PubMed ID: 16444432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine and cellular fibronectin are increased in preeclampsia, not transient hypertension of pregnancy.
    Powers RW; Evans RW; Ness RB; Crombleholme WR; Roberts JM
    Hypertens Pregnancy; 2001; 20(1):69-77. PubMed ID: 12044315
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.